TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2025

Amivantamab Plus Lazertinib in Patients With EGFR-Mutant NSCLC After Progression on Osimertinib and Platinum-Based Chemotherapy: Results From CHRYSALIS-2 Cohort A.

Benjamin Besse et al.PubMed ↗Publisher ↗

No numbers read from the abstract.